[摘è¦] 目的 探索原ä½ä¸€æœŸé™è„‰åŠ¨è„‰åŒ–æ–¹å¼æ²»ç–—脉管炎åŠåŠ¨è„‰ç¡¬åŒ–é—塞症的临床应用å¯è¡Œæ€§ã€‚方法 方便收集2011å¹´6月—2014å¹´12月该院采用é™è„‰ç“£è†œåˆ‡é™¤æˆ–ç ´åã€åŽŸä½ä¸€æœŸé™è„‰åŠ¨è„‰åŒ–æ²»ç–—çš„56例(61æ¡æ‚£è‚¢)脉管炎患者åŠ60例(81æ¡æ‚£è‚¢)动脉硬化é—å¡žç—‡ï¼Œè§‚å¯Ÿæœ¯åŽæ‚£è€…行走和患肢缺血状æ€ã€ç–¼ç—›ã€çš®è‚¤ç‰æƒ…况。结果142æ¡æ‚£è‚¢æœ¯åŽæ‚£è‚¢ç¼ºè¡€ç—‡çŠ¶æ˜Žæ˜¾æ”¹å–„ï¼Œ26ä¾‹å‰§çƒˆé™æ¯ç—›æ˜Žæ˜¾ç¼“解。所有患者é™è„‰æåŠ¨è‰¯å¥½ï¼Œè‚¢ç«¯å¾ªçŽ¯æ˜¾è‘—æ”¹å–„ï¼Œçš®è‚¤æ¸©åº¦è¾ƒå‰å‡é«˜ã€‚67ä¾‹æ‰‹æœ¯åŽæ‚£è‚¢æœ«æ¢¢å³ç”±é’紫色å˜ä¸ºæš—红色,皮肤温度æ¢å¤æ£å¸¸ã€‚术åŽéšè®¿6~24个月,肢缺血症状完全消失,å疽足趾脱è½ï¼Œæ®‹ç«¯å®Œå…¨æ„ˆåˆï¼Œè¸ä¸Šå¤§éšé™è„‰è§¦åŠæåŠ¨ã€‚ 结论 é™è„‰ç“£è†œåˆ‡é™¤æˆ–ç ´åã€åŽŸä½ä¸€æœŸé™è„‰åŠ¨è„‰åŒ–æ–¹å¼æ²»ç–—脉管炎åŠåŠ¨è„‰ç¡¬åŒ–é—塞症效果良好,值得推广。
[关键è¯] é™è„‰åŠ¨è„‰åŒ–ï¼›è„‰ç®¡ç‚Žï¼›åŠ¨è„‰ç¡¬åŒ–é—塞症;手术
[ä¸å›¾åˆ†ç±»å·] R4 [æ–‡çŒ®æ ‡è¯†ç ] A [æ–‡ç« ç¼–å·] 1674-0742(2016)05(b)-0017-03
[Abstract] Objective To explore the clinical application feasibility of primary in situ vein graft arterialization method in treatment of vasculitis and arteriosclerosis obliterans. Methods 56 cases of patients with vasculitis(61 affected limbs) and 60 cases of patients with arteriosclerosis obliterans (81 affected limbs) treated with venous valve removal or destruction and primary in situ vein graft arterialization therapy in the department of orthopaedics from June 2011 to December 2014 were collected ...... 第 1 2 页 下一页
百拇医è¯ç½‘ http://www.100md.com/html/paper/1674-0742/2016/14/06.htm
您现在查看是摘è¦é¡µï¼Œå…¨æ–‡é•¿ 4124 å—符。
